NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events
Research Theme

Clinical Informatics and Big Data

You are here: Home > News listings for Clinical Informatics and Big Data

News for Clinical Informatics and Big Data

“Modest” increase in heart attack hospitalisation rates after years of decline

13 July 2021 · Listed under Cardiovascular, Clinical Informatics and Big Data

The burden of hospital admission rates due to heart attacks in England rose between 2012 and 2016, despite decades of falling rates, new research suggests. The researchers also found that after 2010-2011, admission rates increased in most age groups. Young women aged 35 to 49 and even younger men aged 15 to 34 were the … Read more

RECOVERY Trial identifies another effective COVID-19 treatment

16 June 2021 · Listed under Clinical Informatics and Big Data, COVID-19

The RECOVERY Trial, the world’s largest randomised trial of potential COVID-19 treatments, has found that a monoclonal antibody combination developed by US company Regeneron reduces deaths for hospitalised COVID-19 patients who have not mounted their own immune response. The RECOVERY Trial, which is led from Oxford and supported by the NIHR Oxford BRC, was established as a randomised … Read more

BRC-supported researchers recognised in Queen’s Birthday Honours

11 June 2021 · Listed under Clinical Informatics and Big Data, COVID-19, Vaccines for Emerging and Endemic Diseases

A number of NIHR Oxford BRC-supported researchers who have played prominent roles in the global response to the COVID-19 pandemic have been honoured as part of the Queen’s Birthday Honours List. The researchers, who have developed new vaccines or identified new drug treatments, have saved many lives around the world. Among the BRC researchers recognised … Read more

RECOVERY trial finds aspirin does not improve survival for hospitalised COVID-19 patients

9 June 2021 · Listed under Clinical Informatics and Big Data, COVID-19

The RECOVERY Trial, the world’s largest randomised trial of potential COVID-19 treatments, has found that in patients hospitalised with COVID-19, aspirin is not associated with reductions in mortality or in the risk of progressing to invasive mechanical ventilation or death. In results published on the pre-print server medRxiv, the trial team found that aspirin was associated with a small … Read more

Artificial intelligence tool for streamlining pathology workflow

26 May 2021 · Listed under Clinical Informatics and Big Data, Imaging, Molecular Diagnostics, Multi-Modal Cancer Therapies

A multidisciplinary team comprising University of Oxford academics and Oxford University Hospitals (OUH) pathologists has developed an algorithm that automates requests for additional investigation of diagnostically uncertain prostate biopsies. The team were supported by the NIHR Oxford BRC through its Molecular Diagnostics and Imaging themes. Nearly 50,000 cases of prostate cancer are diagnosed each year … Read more

Trial finds no benefit from using colchicine in hospitalised COVID-19 patients

19 May 2021 · Listed under Clinical Informatics and Big Data, COVID-19

The RECOVERY Trial, the world’s largest randomised trial of potential COVID-19 treatments, has found no evidence that that the drug colchicine has any meaningful clinical benefits for patients hospitalised with COVID-19. Colchicine is used to treat inflammation and pain in conditions such as gout. Because of its anti-inflammatory qualities, it had been proposed as a potential treatment for COVID-19. … Read more

BRC researcher receives national infection prevention award

17 May 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data

An NIHR Oxford Biomedical Research Centre researcher who has played a leading role in Oxford University Hospitals (OUH) NHS Foundation Trust’s COVID-19 staff testing programme is to receive a national award. Dr David Eyre (pictured) has been named as the recipient of the Healthcare Infection Society’s (HIS) 2021 Early Career Award in recognition of his … Read more

Oxford BRC researchers named among new Academy of Medical Sciences fellows

12 May 2021 · Listed under Clinical Informatics and Big Data, COVID-19, Gastroenterology and Mucosal Immunity, Neurological Conditions, Vaccines for Emerging and Endemic Diseases

A number of leading researchers supported by the NIHR Oxford Biomedical Research Centre are among 50 prominent biomedical and health scientists elected to the Academy of Medical Sciences’ respected and influential Fellowship. The new Fellows include Oxford BRC experts who have spearheaded the COVID-19 response, such as Professor Sarah Gilbert, who led the team developing … Read more

Data reveals COVID-19 risk factors for people with type 1 diabetes

11 May 2021 · Listed under Clinical Informatics and Big Data, COVID-19, Diabetes and Metabolism

The largest study of people with type 1 diabetes admitted to hospital with COVID-19 has found that those with higher body mass index (BMI), poorer kidney function and the presence of microvascular complications were at greater risk of death and/or admission to intensive care. However, the study, supported by the NIHR Oxford Biomedical Research Centre, … Read more

Study highlights role of BMI in increased COVID-19 risks

29 April 2021 · Listed under Clinical Informatics and Big Data, COVID-19, Obesity, Diet and Lifestyle

A study by University of Oxford researchers has found that the risk of admission to hospital, admission to ICU or death from COVID-19 increases progressively above a ‘normal’ BMI of 23, even without other comorbidities. The research team, who are supported by the NIHR Oxford Biomedical Research Centre (BRC), found that BMI is a greater … Read more

National survey reveals big reductions in COVID-19 infections with single dose of Oxford-AZ and Pfizer vaccines

23 April 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data, COVID-19, Vaccines for Emerging and Endemic Diseases

Data from the national COVID-19 Infection Survey, which is led by senior NIHR Oxford BRC researcher Professor Sarah Walker, has revealed the impact of vaccination on antibody responses and new infections in a large group of adults from the general population. This major community surveillance survey, one of the NIHR’s COVID-19 urgent public health studies, … Read more

New clinical prediction tools for myeloma developed

9 April 2021 · Listed under Clinical Informatics and Big Data, Multi-Modal Cancer Therapies

University of Oxford researchers have developed new clinical prediction models for use in primary care with the aim of accelerating the diagnosis of myeloma, a cancer of the bone marrow. Myeloma caused 117,077 deaths worldwide in 2020. Earlier diagnosis improves the rate of survival but unfortunately, delays in myeloma diagnosis are common and result in … Read more

Risk of severe COVID-19 from asthma and other respiratory diseases may be only modestly increased, new analysis suggests

1 April 2021 · Listed under Clinical Informatics and Big Data, COVID-19, Obesity, Diet and Lifestyle, Respiratory

An analysis of 8.3 million health care records in England shows that people with asthma have only a small increased risk of developing severe Covid-19. The study, led by University of Oxford researchers, examined routine patient data collected between January and April 2020 to generate risk assessments for severe COVID-19 in people with chronic respiratory … Read more

Two doses of vaccine offer same protection from COVID as prior infection, study finds

15 March 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data, COVID-19, Vaccines for Emerging and Endemic Diseases

Two doses of either the Pfizer or Oxford-AstraZeneca vaccine offer similar protection against symptomatic SARS-CoV-2 infection to that coming from natural immunity after infection, an ongoing study of healthcare workers has found. None of the 1,456 healthcare workers at Oxford University Hospitals (OUH) NHS Foundation Trust who had received two vaccines had a symptomatic infection … Read more

Oxford study shows high level of readmissions and death after COVID-19 discharge

22 February 2021 · Listed under Clinical Informatics and Big Data, COVID-19

Some 30% of patients discharged after being admitted to hospital with community-acquired COVID-19 had been readmitted or died within 60 days, a study by Oxford researchers has shown. In a paper published in the European Journal of Public Health, they found that, as anticipated, rates of readmission or death were higher among older adults. However, … Read more

Oxford-led technology to help those at high risk from Covid-19

16 February 2021 · Listed under Clinical Informatics and Big Data, COVID-19, Multimorbidity and Long-Term Conditions

More people in England at high risk from Covid-19 will get priority access to vaccines thanks to new technology developed by a University of Oxford-led team of researchers that can identify those who may be most vulnerable to the virus. Research led by Professor Julia Hippisley-Cox in the University of Oxford’s Nuffield Department of Primary … Read more

Tocilizumab found to reduce deaths in hospitalised COVID-19patients

11 February 2021 · Listed under Clinical Informatics and Big Data, COVID-19

The RECOVERY Trial, the world’s largest randomised trial of potential COVID-19 treatments, has found that the anti-inflammatory drug, tocilizumab, reduces the risk of death when given to hospitalised patients with severe COVID-19. The trial, which received core funding from the NIHR Oxford Biomedical Research Centre (BRC), also showed that tocilizumab shortens the time until patients … Read more

Lateral flow devices found to be useful in screening OUH staff for coronavirus

11 February 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data, COVID-19

Infection prevention and control clinicians and researchers at Oxford University Hospitals (OUH) have been outlining the OUH’s experience of deploying self-administered home-based lateral flow testing of its staff. In a letter published in the Journal of Infection, they said that 46,503 home-based SARS-CoV-2 lateral flow tests had been performed by asymptomatic OUH hospital staff. Of … Read more

Fewer colorectal cancer diagnoses reported during COVID-19

29 January 2021 · Listed under Clinical Informatics and Big Data, COVID-19

University of Oxford researchers from the UK Colorectal Cancer Intelligence Hub have been investigating how the diagnosis and treatment of colorectal cancer patients has been affected by the COVID-19 pandemic. The NIHR Oxford BRC-supported researchers at the Nuffield Department of Population Health carried out the analysis with NHS Digital and experts from other UK universities … Read more

Lateral flow devices detect most infectious COVID-19 cases, study shows

22 January 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data, COVID-19

Researchers from the University of Oxford, working with Public Health England, have used NHS Test and Trace data to find out why some individuals pass COVID-19 on to their contacts more easily than others, and if lateral flow tests are sufficient in detecting those who are most infectious.  Using information from over a quarter of … Read more

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Clinical Informatics and Big Data Theme

  • Introduction
  • Contacts
  • Videos for this theme
  • News for this theme
  • General News Listings

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre